FDA to Prioritize Full Approval for Pfizer COVID Vaccine
FRIDAY, July 16, 2021 (HealthDay News) — Pfizer Inc. announced on Friday that the U.S. Food and Drug Administration has granted priority review to its COVID-19 vaccine, positioning the vaccine for full approval by January. The Pfizer vaccine has been administered to more Americans than any other shot so farContinue Reading










